Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial
Year: 2006
Type: article
Study design: Clinical Trial
Source: Annals of Oncology
Authors: F. Boccardo, A. Rubagotti, P. Guglielmini, A. Fini, G. Paladini, M. Mesiti, M. Rinaldini, S. Scali, M. Porpiglia, C. Benedetto, N. Restuccia, F. Buzzi, R. Franchi, B. Massidda, V. Distante, D. Amadori, P. Sismondi
Institutions: Ospedale Policlinico San Martino, University of Genoa, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, Ospedale Sant'Anna, University of Turin, University of Messina, Ospedale San Donato, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Azienda Ospedaliera S.Maria, University of Cagliari, University of Florence, Ospedale G.B. Morgagni - L.Pierantoni
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Keywords: anastrozole, tamoxifen, treatment switching, early breast cancer, adjuvant endocrine therapy, aromatase inhibitors, endocrine therapy resistance, disease-free survival, event-free survival, overall survival, postmenopausal women, node-positive breast cancer, estrogen receptor-positive breast cancer, adverse events
Open Access status: bronze
OpenAlex ID: W2103933822
